Adagio Therapeutics Stock Price

-0.0817 (-1.15%)
Upgrade to Real-Time
Regular Market
Volume 489,204
Bid Price 6.99
Ask Price 7.01
News -
Day High 7.59


52 Week Range


Day Low 6.88
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Adagio Therapeutics Inc ADGI NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0817 -1.15% 7.0083 10:25:09
Open Price Low Price High Price Close Price Prev Close
7.17 6.88 7.59 7.09
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
4,042 489,204 $ 7.21 $ 3,528,003 - 4.92 - 78.82
Last Trade Time Type Quantity Stock Price Currency
10:25:09 1 $ 7.00 USD


Draw Mode:

Adagio Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 779.69M 111.25M 64.02M $ - $ - -1.25 -2.70
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 640.07k 1.90%

more financials information »

Adagio Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ADGI Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week5.627.955.516.614,656,3891.3924.7%
1 Month7.608.054.926.044,497,860-0.5917-7.79%
3 Months31.4278.824.9214.499,046,976-24.41-77.69%
6 Months21.0078.824.9215.934,615,179-13.99-66.63%
1 Year21.0078.824.9215.934,615,179-13.99-66.63%
3 Years21.0078.824.9215.934,615,179-13.99-66.63%
5 Years21.0078.824.9215.934,615,179-13.99-66.63%

Adagio Therapeutics Description

Adagio Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company's lead product candidate, ADG20 is developed for the treatment and prevention of coronavirus disease 2019, or COVID-19, the disease caused by the virus SARS-CoV-2 and its variants.
Your Recent History
Adagio The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20220127 15:40:11